Exhibit 10.1
EXECUTION VERSION
First Amended and
Restated
PARTICIPATION
AGREEMENT
Between
INTERNATIONAL BUSINESS MACHINES
CORP.
And
ADVANCED MICRO DEVICES,
INC.
Dated
August 15,
2008
1
[****] = Certain confidential information
contained in this document, marked by brackets, has been omitted
and filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as
amended. Confidential treatment has been requested with respect to
the omitted portions.
EXECUTION VERSION
This
Participation Agreement (“Participation
Agreement”) is made effective as of the twenty-fifth
(25 th ) day of June, 2008
(hereinafter referred to as the “Effective Date”) by
and between International Business Machines Corporation
(“IBM”) , incorporated under the laws of the State
of New York, U.S.A. and having an office for the transaction of
business at 2070 Route 52, Hopewell Junction, NY 12533, U.S.A, and
Advanced Micro Devices, Inc. (“AMD” or
“Company”) , incorporated under the laws of the
State of Delaware, U.S.A, and having an office for the transaction
of business at One AMD Place, Sunnyvale, CA 94088-3453 for the
Development Projects referenced on Exhibit A attached hereto
(collectively, the “Development Projects”).
WHEREAS , IBM and Company previously entered into the
Third Amendment and Restatement of the “S” Process
Development Agreement as of December 28, 2002 (hereinafter
“SPDA”) to develop certain SOI process
technologies;
WHEREAS , IBM is pursuing or intends to pursue each of
the Development Projects alone or in conjunction with one or more
Participating Parties, as such Development Projects are more
particularly described in the Project Agreements;
WHEREAS , Company seeks to participate as a
Participating Party in each of the Development Projects with IBM
and the other applicable Participating Parties; and
WHEREAS , IBM seeks to permit such participation in each
of the Development Projects based upon the terms and conditions set
forth in (i) the applicable Project Agreement (including the
Master Terms), which governs matters between and among all Parties,
and (ii) this Participation Agreement, which governs certain
supplemental matters between IBM and Company.
NOW THEREFORE
, in consideration of the premises
and mutual covenants contained herein, as well as for other good
and valuable consideration, the receipt and sufficiency of which is
hereby acknowledged, IBM and Company agree as follows.
1. Additional
Definitions. Unless
expressly defined and used with an initial capital letter in this
Participation Agreement, the Project Agreement, or the Master
Terms, words shall have their normally accepted meanings. Each of
the following terms has the meaning ascribed to it
below:
“Baseline Fees” is
defined in Section 5(a).
“BEOL” (Back End of
Line) shall mean those aspects of Background Know-How and Specific
Results that are directed to methods and processes of
interconnecting the source, gate, or drain electrodes of FET
transistors formed on a wafer, including initial passivation of
such FET transistors with a dielectric, up to and including
polyimide passivation and final via formation but not including
Packaging Technology. For the avoidance of doubt,
“BEOL” shall not include local interconnects made of
tungsten.
“Company Participation
Period(s)” is defined in Section 3.
2
[****] = Certain confidential information
contained in this document, marked by brackets, has been omitted
and filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as
amended. Confidential treatment has been requested with respect to
the omitted portions.
EXECUTION VERSION
“Derivative Process(es)”
shall have the meaning ascribed to it in
Section 7(f).
“Development Projects”
means those particular Development Projects identified on Exhibit
A.
“Foundry Company(ies)”
means an entity having a majority of its revenue arising from the
sale of Integrated Circuits wherein all the following conditions
are met: (i) the design, or masks and/or mask build data, for
such Integrated Circuit product are provided to the Foundry Company
from a party other than the Foundry Company; (ii) such Foundry
Company played no substantial role in any phase of the design of
such product (except for providing standard design libraries,
design enablement tools or other intellectual property to the party
other than the Foundry Company to specifically assist with the
design of the product); and (iii) such Foundry Company is
contractually bound to manufacture such product solely for, and to
sell such product solely to, such party other than the Foundry
Company or its distributor or other recipient solely for the
benefit of such party other than the Foundry Company. Foundry
Company also includes any other entity that has as its primary
business the manufacture of Industry Standard Integrated Circuits,
wherein at least fifty percent (50%) of the ownership interest
in such entity is held by a Foundry Company (as defined in the
first sentence of this paragraph), and wherein such Foundry Company
and no other entity provides day-to-day control and decision-making
authority as to the manufacturing operations of such
entity.
“Foundry Entity” means a
Third Party entity which derived more than [****] dollars of
revenue from sale of foundry products (defined as for Foundry
Products except with such entity named in place of Company) in
fiscal year 2007.
“Foundry Product” means
an Integrated Circuit wherein all the following conditions are met:
(i) the design, or masks and/or mask build data, for such
Integrated Circuit product are provided to Company from a Third
Party; (ii) Company played no substantial role in any phase of
the design of such product (except for providing standard design
libraries, design enablement tools or other intellectual property
to the Third Party to specifically assist with the design of the
product); and (iii) Company is contractually bound to
manufacture such product solely for, and to sell such product
solely to, such Third Party or its distributor or other recipient
solely for the benefit of such Third Party.
“High Performance
Information” means aspects of Background Know-How or Specific
Results of any one or more Development Projects, except for
Industry Standard Information.
“Industry Standard Development
Projects” means the Development Projects pursuant to any of
the following Project Agreements:
(1) [****]; or
(2) [****]; or
(3) [****]; or
3
[****] = Certain confidential information
contained in this document, marked by brackets, has been omitted
and filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as
amended. Confidential treatment has been requested with respect to
the omitted portions.
EXECUTION VERSION
(4) [****];
(5) [****]; or
(6) [****].
“Industry Standard
Information” means Background Know-How or Specific Results of
any Industry Standard Development Project and Background Know-How
or Specific Results of any other Development Projects other than
Protected High Performance Information selected by IBM and Company
pursuant to Section 7(f).
“JMP” means a Third
Party who is licensed by Company pursuant to Section 7(a) of
this Participation Agreement to manufacture Integrated Circuits in
a joint manufacturing facility utilizing the Background Know-How
and Specific Results of any Development Project (excluding High
Sensitivity Pre-T0 Information).
“Key Information” means
Industry Standard Information that enables a Third Party to engage
in installation of the unit process modules, process integration
flow, or yield enhancement activities of the relevant technology
excluding information that enables a licensee of such Key
Information to 1) sign and confirm that a license exists, 2)
present an implementation roadmap for the licensed technology, and
3) build and equip a manufacturing facility, excluding specific
recipe details.
“Master Terms” means the
Master IBM Joint Development Terms and Conditions that are
incorporated by reference into the Project Agreements.
“Net Sales” means the
net revenue recorded by Company (including its Wholly Owned
Subsidiaries) with respect to the first sale or other transfer of
unbumped product wafers less (a) shipping, (b) insurance,
and (c) sales, value added, use or excise taxes, to the extent
to which such items (a), (b) or (c) are actually paid or
allowed, and less allowances to the extent they are actually
allowed. If such wafers are sold or otherwise transferred in a
higher level of assembly or with further processing or in the
course of a transaction that includes other products or services
with no separate bona fide price to be charged for such wafers, the
applicable Net Sales for the purpose of calculating Revenue Based
Fees shall be the fair market value of the unbumped
wafers.
“Participation Effective
Date” means, for each Development Project, the earlier date
referenced under Company Participation Period in Exhibit A for the
respective Development Project.
“Participation
Agreement” means this “First Amended and Restated
Participation Agreement between International Business Machines
Corporation and Advanced Micro Devices, Inc.”
“Project Agreement”
means the Project Agreement governing the respective Development
Project, as referenced on Exhibit A.
“Protected High Performance
Information” is defined in Section 7(f).
4
[****] = Certain confidential information
contained in this document, marked by brackets, has been omitted
and filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as
amended. Confidential treatment has been requested with respect to
the omitted portions.
EXECUTION VERSION
“Revenue Based Fees” is
defined in Section 5(b).
“ SOI Wafer” shall mean a
single-crystal silicon wafer bearing a horizontally-disposed
isolating silicon dioxide (SiO 2 ) layer, in turn bearing a
single-crystal silicon layer or a polysilicon layer, which is
separated from the underlying silicon by the silicon dioxide layer
and in which one or more active or passive integrated circuit
structures are formed.
“SPDA” is defined in the
recitals of this Participation Agreement.
2. Binding Contract;
Relationship to the SPDA.
(a) By executing this Participation
Agreement and the respective “Participating Party
Notification” attached as Exhibit C and upon Company board
approval, such approval to be received no later than
September 15, 2008 (absent such approval this Agreement shall
be null and void ab initio and any Confidential Information
received hereunder shall be destroyed), (i) Company joins each
of the respective Development Projects as a Participating Party,
(ii) Company and the other Participating Parties are each
directly contracted to IBM and to each other based upon the terms
and conditions of the respective Project Agreement (including the
Master Terms and any language herein applicable to the respective
Project Agreements), without the need for any additional
documentation or signatures by any Party, and (iii) Company is
estopped from contesting its direct privity of contract with the
other Participating Parties and with IBM on such referenced terms
and conditions. Exhibit D provides a list of the Participating
Parties in each of the Development Projects as of the Participation
Effective Date. IBM will record updates to this list on the
respective Project Database.
(b) Company and IBM recognize that
certain of their bilateral development effort pursuant to the SPDA
must be replaced in order to facilitate IBM and Company’s
continued development with other Participating Parties pursuant to
the applicable Development Projects. Accordingly, IBM and Company
agree that, as of the Participation Effective Date, the development
activities pursuant to the SPDA, or portions thereof, listed in
Exhibit E to this Participation Agreement permanently end and such
development recommences pursuant to such Project Agreements and
this Participation Agreement. The SPDA continues in full force and
effect, however the parties hereto contemplate terminating the
SPDA, in part, in the future subject to negotiating which of the
SPDA’s provisions will survive. Notwithstanding the
foregoing, as of the date of the last signature hereto, for the
Development Projects listed in Exhibit A this Agreement shall
supercede the provisions of Sections 5.1-5.3, 5.6, 5.7, 5.8, 5.10,
5.11 and 4.6 of the SPDA.
(c) The language in Exhibits F and G
attached hereto contain additional Company-specific terms and
conditions agreed to by IBM and Company. Such terms and conditions
are incorporated herein and form an integral part of the
Agreement.
5
[****] = Certain confidential information
contained in this document, marked by brackets, has been omitted
and filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as
amended. Confidential treatment has been requested with respect to
the omitted portions.
EXECUTION VERSION
3. Company Participation
Periods; Term. Company shall participate and is only authorized
to participate in the Development Project(s), commencing on the
Participation Effective Date and continuing for the applicable
periods for the Project Agreements referenced in Exhibit A attached
hereto (“Company Participation Period(s)”), regardless
of whether the applicable Project Term extends beyond a Company
Participation Period for such Development Project. The term of this
Participation Agreement shall commence on the Effective Date and,
unless terminated prior to expiration as set forth elsewhere in the
Agreement, shall remain in force until the earlier of
(i) expiration or earlier termination of all Project
Agreements referenced on Exhibit A, or (ii) December 31,
2015.
4. Company
Staffing. Company
shall provide IBM with Representatives to work on the Development
Projects in accordance with the minimum staffing levels detailed on
Exhibit B attached hereto.
5. Company Contributions and
Other Payments . In
consideration for Company’s right to participate in the
Development Projects commencing as of the Participation Effective
Date, Company shall timely pay IBM quarterly development fees which
are the greater of Baseline Fees pursuant to subsection
(a) below or Revenue Based Fees pursuant to subsection
(b) below. Company’s contributions will be calculated
during the second calendar quarter of each year and be in effect
for the subsequent four calendar quarters. Beginning in the fourth
calendar quarter of 2008, all such payments shall be made within
forty-five (45) days after receipt by Company of a quarterly
invoice from IBM but no earlier than on the fifteenth day of the
first month of each calendar year quarter. For the third calendar
quarter of 2008, such payments shall be made within forty-five
(45) days after receipt by Company of an invoice from IBM but
in no case later than September 30, 2008.
6
[****] = Certain confidential information
contained in this document, marked by brackets, has been omitted
and filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as
amended. Confidential treatment has been requested with respect to
the omitted portions.
EXECUTION VERSION
|
(a)
|
Baseline Fees,
in millions of dollars per calendar quarter, shall be determined
according to the tables below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3Q08
|
|
4Q08
|
|
1Q09
|
|
2Q
|
|
3Q
|
|
4Q
|
|
1Q10
|
|
2Q
|
|
3Q
|
|
4Q
|
|
1Q11
|
|
2Q
|
|
3Q
|
|
4Q
|
|
1Q12
|
|
[****]
|
|
[****]
|
|
[****]
|
|
[****]
|
|
[****]
|
|
[****]
|
|
[****]
|
|
[****]
|
|
[****]
|
|
[****]
|
|
[****]
|
|
[****]
|
|
[****]
|
|
[****]
|
|
[****]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2Q12
|
|
3Q
|
|
4Q
|
|
1Q13
|
|
2Q
|
|
3Q
|
|
4Q
|
|
1Q14
|
|
2Q
|
|
3Q
|
|
4Q
|
|
1Q15
|
|
2Q
|
|
3Q
|
|
4Q
|
|
[****]
|
|
[****]
|
|
[****]
|
|
[****]
|
|
[****]
|
|
[****]
|
|
[****]
|
|
[****]
|
|
[****]
|
|
[****]
|
|
[****]
|
|
[****]
|
|
[****]
|
|
[****]
|
|
[****]
|
(b) Revenue Based Fees shall be
calculated based on Company’s Net Sales during
Company’s preceding fiscal year of products or services
manufactured using, embodying, derived from or otherwise based upon
any Background Know-How or Specific Results of a Development
Project as follows:
(i) [****] percent ([****]%) of Net
Sales for products, consumed by Advanced Micro Devices, Inc., or
sold or transferred to Advanced Micro Devices, Inc. by any
permitted assignee hereunder of Advanced Micro Devices, Inc., based
upon substantially all of the High Performance Information derived
from the relevant high performance Development Project,
plus;
(ii) [****] percent ([****]%) of Net
Sales (excluding for clarity Net Sales from (i) above) for
products, consumed by Advanced Micro Devices, Inc., or sold or
transferred to Advanced Micro Devices, Inc. by any permitted
assignee hereunder of Advanced Micro Devices, Inc., based upon
Industry Standard Information, plus;
(iii) [****] percent ([****]%) of
Net Sales for products based upon Specific Results or Background
Know-How of any Development Project and sold to, transferred to or
consumed by any third party who is licensed by IBM to manufacture
products using Specific Results or Background Know-How of the same
Development Project, plus;
(iv) [****] percent ([****]%) of Net
Sales for products based upon Specific Results or Background
Know-How of any Development Project and sold to, transferred to or
consumed by any third party who is licensed by IBM to Specific
Results or Background Know-How of the same Development Project
wherein such license does not include the right to manufacture
products using such Specific Results or Background Know-How,
plus;
(v) [****] percent ([****]%) of Net
Sales for products sold to, transferred to or consumed by any other
third party.
7
[****] = Certain confidential information
contained in this document, marked by brackets, has been omitted
and filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as
amended. Confidential treatment has been requested with respect to
the omitted portions.
EXECUTION VERSION
The percentage values stated above
in 5(b)(i) through (v) will prospectively change to [****],
[****], [****], [****], and [****] percent, respectively, should
Company merge with or acquire (including reverse merger or reverse
acquisition) [****] (“[****]”) while [****] is a
Participating Party in a major node IBM Development Project or
within nine (9) months after [****] ceases to be a
Participating Party in a major node IBM Development
Project.
For avoidance of doubt each product
consumed by, sold to or transferred to Advanced Micro Devices, Inc.
or any third party shall fall under only one revenue category under
subsections 5.(b)(i) through (v) above for purposes of
calculating Revenue Based Fees.
Company’s quarterly Revenue
Based Fees shall be one quarter of the amount indicated above. For
avoidance of doubt, the establishment of a half-node process
technology Development Project(s) and Company’s participation
in such project(s) will not increase Company’s fee
schedule.
Company’s total yearly Revenue
Based Fees in any given year shall not exceed two (2) times
the corresponding yearly amount of Company’s Baseline Fees
indicated above. Should Company merge with or acquire (including
reverse merger or reverse acquisition) [****]
(“[****]”) then Company’s total yearly Revenue
Based Fees in that year and any subsequent year shall not exceed
three (3) times the corresponding yearly amount of
Company’s Baseline Fees indicated above.
To the extent it has the right to do
so, which right IBM will make a good faith effort to obtain, IBM
shall promptly notify Company after it enters into, or terminates
or alters, any relevant licensing arrangement affecting the
appropriate categorization of transfers above which would allow
Company to correctly calculate Revenue Based Fees under subsections
(iii) and (iv) above. Company shall not be liable for any
underpayments which result from IBM’s failure to provide such
notification. No later than March 31 of each calendar year,
Company shall provide to IBM a written statement containing
Company’s Net Sales during the preceding fiscal year in each
of the above categories, the calculated percentages according to
the above and the total amount of Revenue Based Fees. Company shall
maintain a complete, clear and accurate record of the quantity of
products sold or otherwise transferred or consumed and any other
relevant information to the extent it is required to determine
whether they are reporting the correct Revenue Based Fees
hereunder. To ensure compliance with the terms and conditions of
this Agreement, IBM shall have the right to audit all relevant
accounting, technical and sales books and records of Company. The
audit will be conducted by a mutually acceptable audit firm, and
shall be conducted following reasonable prior written notice (at
least forty-five (45) days in advance) during regular business
hours at an office where such records are normally maintained and
in such a manner as not to interfere with Company’s normal
business activities and shall be restricted only to those records
necessary to verify Company’s obligations hereunder. The
audit report provided to IBM may only include
8
[****] = Certain confidential information
contained in this document, marked by brackets, has been omitted
and filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as
amended. Confidential treatment has been requested with respect to
the omitted portions.
EXECUTION VERSION
the information necessary to determine whether
or not any underpayment or overpayment exists, and if it exists,
the amount of such underpayment or overpayment. IBM shall instruct
the auditor to include only business information in the audit
report to IBM. IBM shall use the business information reported by
the auditor only for the purpose of determining royalty payments
and for no other purpose. In no event shall audits be made
hereunder more frequently than once in every twelve
(12) months and the audit shall not cover any records from a
period of time previously audited. If any audit should disclose any
underpayment or overpayment, the owing Party shall within
forty-five (45) days pay the difference. The cost of such
audit will be borne by IBM. Company shall be provided with a copy
of the audit report within a reasonable period of time after its
completion. The independent audit firm shall not be hired on a
contingent fee basis and Company shall have the right to require
such audit firm to sign a confidentiality agreement sufficient to
protect Company’s confidential information.
(c) Company shall be liable for
interest on any overdue payment under this Agreement commencing on
the date such payment becomes due at an annual rate equal to
eighteen percent (18%) per year. If such interest rate exceeds
the maximum legal rate in the jurisdiction where a claim therefor
is being asserted, the interest rate shall be reduced to such
maximum legal rate.
(d) IBM shall apply the payments of
this Section 5 towards Development Project costs and not for
any license rights granted by any Party to any other Party for
Background Know-How.
(e) In consideration for the
licenses granted to Company to Background Know-How of the 32nm Bulk
Industry Standard Semiconductor Process Technology and 32nm
Bulk-Industry Standard Enablement Technology Development Projects,
Company shall pay to IBM [****] dollars ($[****]) according to the
following schedule: $[****] on or before September 30, 2008;
$[****] on or before December 30, 2008, $[****] on or before
January 15, 2009; $[****] on or before April 15, 2009 and
$[****] on or before July 15, 2009; which obligation shall be
irrevocable and which payment when made shall be non-refundable.
The first two payments under this section will be due and payable
on the respective dates specified with this Agreement serving as
the invoice. All subsequent payments shall be made within
forty-five (45) days after receipt by Company of a quarterly
invoice from IBM; however, in no case will Company be required to
payment before the dates specified above.
(f) Each Party shall bear and pay
all taxes (including, without limitation, sales and value added
taxes) imposed upon it by the national government or political
subdivision thereof, of any country in which they are doing
business as a result of the existence of this Agreement or the
exercise of its rights hereunder. Except as expressly provided in
this Agreement, neither Party shall be entitled to any payment,
cost reimbursement, or other compensation from the other for
services, deliverables and rights granted to the other Party
hereunder. Each Party shall bear all its own expenses incurred in
the performance of this Agreement. All payments due hereunder shall
be paid in United States dollars.
9
[****] = Certain confidential information
contained in this document, marked by brackets, has been omitted
and filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as
amended. Confidential treatment has been requested with respect to
the omitted portions.
EXECUTION VERSION
6. Limitation
Amount. Notwithstanding the Limitation Amount provided
in the Project Agreement, the Limitation Amount as between IBM and
Company for all Development Projects in the aggregate is [****]
dollars.
7. Confidentiality;
Information Transfers; Licenses to Background
Know-How.
(a) Joint Manufacturing
Rights. IBM hereby grants to Company the right to disclose and
sublicense Background Know-How and Specific Results of any
Development Project (excluding High Sensitivity Pre-T0 Information)
subject to the following requirements. Company may sublicense no
more than two (2) JMPs for a maximum of a total of two
(2) joint manufacturing facilities with a combined maximum
capacity of producing [****] 300 mm wafers per month for such
technology consumed by, or supplied to the JMPs. Said combined
maximum volume amount for a specific technology will apply until
the confidentiality period for that specific technology expires.
Company must own greater than fifty percent (50%) interest
(defined in the same manner as for Subsidiary) in the joint
manufacturing facility and the JMP own the remaining interest
except for any interest owned by a government entity or
institutional investor (“Inactive Owners”). The
Inactive Owners shall not be in the business of manufacturing
Integrated Circuits and will not be granted access to any Key
Information. Company and the JMP will provide day-to-day control
and decision making authority as to the manufacturing operations of
their joint manufacturing facility. The JMP will derive no more
than fifty percent (50%) of its total revenue from foundry
related business. The JMP will not be based in Asia (which for
purposes of this Section 7(a) Asia does not include Japan,
Korea or Singapore). The JMP will not have the right to use the
licensed technology to provide foundry services. The JMP will not
have the right to use the licensed technology other than in the
joint manufacturing facility. The JMP will not be any party who
contracts with IBM to conduct joint development of semiconductor
process technology any sooner than 18 months after the later
termination of either the IBM joint development or joint
manufacturing partner relationship between IBM and such
aforementioned company. The joint manufacturing facility will not
be located in Asia. Notwithstanding the foregoing, [****] may be a
JMP.
If Company builds or has built a
manufacturing facility for the purpose of exercising
Company’s rights and performing Company’s obligations
under the immediately preceding paragraph of this Section 7(a)
and Company and a first or second JMP cannot utilize all of the
combined maximum capacity of [****] 300 mm wafers per month, then
six (6) months prior to start of installation of any process
technology for volume production for any unutilized combined
maximum capacity, and yearly thereafter for any uncontracted,
unutilized combined maximum capacity, Company will so notify IBM in
writing, and IBM will have the right of first refusal of the
unutilized combined maximum capacity at a price to IBM of the then
current average market price for such wafers less twenty percent
(20%), but in no event will such price to IBM be greater than that
offered by Company to its most favored customer under substantially
similar terms and conditions. For the capacity that IBM refuses,
Company may sell foundry wafers
10
[****] = Certain confidential information
contained in this document, marked by brackets, has been omitted
and filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as
amended. Confidential treatment has been requested with respect to
the omitted portions.
EXECUTION VERSION
including Foundry Products subject to this
Section 7(a) to Third Parties (other than those that are not
permitted to be a JMP) provided that: (i) all such sales are
made more than two (2) years after the applicable L2 for the
technology in which such wafers are manufactured and (ii) all
such sales shall be included in the calculation of Revenue Based
Fees under Section 5(b). The foregoing notification obligation
will cease when the confidentiality obligation for a technology
expires.
(b) Have-Made Rights. Except
as expressly provided herein, Company shall have no right to
disclose or sublicense Background Know-How or Specific Results of
any Development Project for the purpose of having products made by
a Third Party in a manufacturing process whose minimum critical
dimension is less than or equal to that of the 32nm High
Performance Semiconductor Process Technology Development Project or
the 32nm Industry Standard Semiconductor Process Technology
Development Project.
(c) Third Party Joint
Development. Except as specifically set forth in a Project
Agreement or in this Participation Agreement, Company shall have no
right to disclose or sublicense Background Know-How or Specific
Results of any Development Project to any Third Party for the
purpose of engaging in joint development of semiconductor process
or design enablement technology with such Third Party.
(d) Foundry Entities. IBM
shall not disclose to a Foundry Entity any Key Information prior to
one (1) year after the applicable Qualification. Furthermore,
IBM shall not allow a Foundry Entity to become a Participating
Party in any Development Project to which Company is a
Participating Party or in which Development Project Company is
actively in negotiation with IBM to become a Participating Party
until six (6) months after IBM has offered participation in
such Development Project to Company or immediately upon Company
declining such participation, whichever is earlier.
(e) Foundry Services.
Notwithstanding anything to the contrary in this Agreement, Company
may use High Performance Information to produce Foundry Products or
produce Foundry Products on SOI Wafers only for sale, lease or
transfer to IBM, other Participating Parties in the Development
Project from which such High Performance Information is derived,
licensees of such High Performance Information from IBM or sale,
lease or transfer to Advanced Micro Devices, Inc. from any
subsequent assignee. For avoidance of doubt, Industry Standard
Information may be used to produce Foundry Products for any Third
Party, subject to all the terms and conditions of this Agreement
including Section 5(b) of this Participation
Agreement.
(f) Derivative Processes and
Protected High Performance Information.
The license granted to Company in
Section 8.1 of the Master Terms shall include the right for
Company to utilize one or more aspects of Industry Standard
Information for the development and qualification of its own,
proprietary derivative process(es) (“Derivative
Process(es)”) and for developing, engineering, manufacturing,
using, marketing, selling, servicing and otherwise disposing of
Integrated Circuits utilizing such Derivative Process(es), other
than Integrated Circuits created using High Performance
Information, such Integrated Circ